Suggestions
Rajan Jethwa
Founder and CEO with a background in surgery
Dr. Rajan Jethwa is a prominent figure in the field of oncology, serving as the Founder and Trustee of the Cancer Platform, an initiative aimed at transforming cancer care through accessible information and innovative treatments. He co-founded this platform alongside Professor Sir Chris Evans, with a vision to enhance patient empowerment and improve cancer treatment navigation.12
Background and Education
Dr. Jethwa has nearly 20 years of experience in the life sciences sector, where he has held various roles including surgeon, investor, and chief executive. He graduated from the University of Cambridge with degrees in Medical Sciences and is a member of the Royal College of Surgeons of England.24 His early experiences as a junior doctor dealing with cancer patients ignited his passion for developing new cancer treatments.2
Career Highlights
- Co-founder of Ellipses Pharma: In 2018, he co-founded Ellipses Pharma, focusing on the rapid development of innovative cancer medicines. The company aims to streamline drug development processes to bring effective treatments to patients more quickly.23
- Cancer Awareness Trust: Alongside his work with the Cancer Platform, he also co-founded the Cancer Awareness Trust, which seeks to create a comprehensive digital educational resource for cancer patients and their caregivers.25
Vision for Cancer Care
Dr. Jethwa's work emphasizes the need for personalized cancer treatment options and better accessibility to clinical trial information. He advocates for a holistic approach that considers individual patient needs throughout their cancer journey.12 His innovative strategies in drug development include a unique model that combines expert vetting of drug candidates with uninterrupted funding to enhance clinical trial efficiency.3
In summary, Dr. Rajan Jethwa is a key player in advancing cancer treatment and patient education through his leadership roles in various organizations dedicated to improving outcomes for those affected by cancer.